The earlier review (31) (N=fifty six patients) discovered higher levels of retrospectively assessed acute worry disorder signs or symptoms and recent PTSD symptoms between patients who been given enantiomer esketamine, compared with those that acquired racemic ketamine or opioids; the racemic ketamine group also showed mildly elevated acute strain